Not applicableUnknownNCT03914352
What this trial is testing
A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
Who this might be right for
Hepatocellular Carcinoma
Cancer Hospital of Guangxi Medical University 40